Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • joint venture

    Tag: joint venture

    You Searched For "joint venture"
    Bayer buys BlueRock in USD 600 million bet on stem cell therapies

    Bayer buys BlueRock in USD 600 million bet on stem cell therapies

    Medical Dialogues Bureau9 Aug 2019 9:00 AM IST
    FRANKFURT: German drugmaker Bayer is paying up to $600 million for full control of cell therapy developer BlueRock Therapeutics, stepping up...
    Pfizer, GSK completes transaction to form new consumer healthcare JV

    Pfizer, GSK completes transaction to form new consumer healthcare JV

    Medical Dialogues Bureau3 Aug 2019 9:40 AM IST
    The Joint Venture brings together two highly complementary portfolios of trusted consumer health brands, including GSK's Sensodyne, Voltaren and...
    GSK, Pfizer gets CCI approval for consumer healthcare JV formation

    GSK, Pfizer gets CCI approval for consumer healthcare JV formation

    Garima25 May 2019 9:45 AM IST
    After the deal, GSK will have a majority controlling equity interest of 68 per cent in the combined consumer healthcare business, while Pfizer will...
    Suven Life Sciences enters asset purchase agreement with Rising Pharma

    Suven Life Sciences enters asset purchase agreement with Rising Pharma

    Garima10 March 2019 11:00 AM IST
    Suven Life Sciences through its joint venture partner, Shore Suven Pharma, Inc has entered into a "stalking horse" asset purchase agreement to buy the...
    Max India in talks to buyout partner in Max Healthcare

    Max India in talks to buyout partner in Max Healthcare

    Ruby Khatun Khatun10 April 2018 4:04 PM IST
    New Delhi: Max India on Monday said its board will consider buying out its equal partner in the healthcare business, Life Healthcare Group Holdings,...
    Magma HDI forays into health insurance with OneHealth policy

    Magma HDI forays into health insurance with OneHealth policy

    Ruby Khatun Khatun2 Dec 2017 9:45 AM IST
    New Delhi: Non-banking finance company Magma Fincorp has forayed into health insurance business through its joint-venture Magma HDI General Insurance...
    AstraZeneca steps up China push with new drug joint venture

    AstraZeneca steps up China push with new drug joint venture

    Ruby Khatun Khatun28 Nov 2017 1:50 PM IST
    LONDON: Drugmaker AstraZeneca plans to turbo-charge its already substantial Chinese business through a new drug development joint venture with a...
    Granules India gets EIR from USFDA for Vizag OmniChem facility

    Granules India gets EIR from USFDA for Vizag OmniChem facility

    Ruby Khatun Khatun8 Oct 2017 10:01 AM IST
    New Delhi: Drug firm Granules India said it has received Establishment Inspection Report (EIR) from the US health regulator for the OmniChem facility...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok